Table: begin end state 1 24 cytoplasmic 25 45 transmembrane 46 51 non-cytoplasmic 52 77 transmembrane 78 98 cytoplasmic 99 127 transmembrane 128 132 non-cytoplasmic 133 152 transmembrane 153 163 cytoplasmic 164 186 transmembrane 187 206 non-cytoplasmic 207 229 transmembrane 230 249 cytoplasmic 250 268 transmembrane 269 279 non-cytoplasmic 280 308 transmembrane 309 339 cytoplasmic 340 361 transmembrane 362 366 non-cytoplasmic 367 392 transmembrane 393 412 cytoplasmic 413 433 transmembrane 434 438 non-cytoplasmic 439 457 transmembrane 458 479 cytoplasmic
Input: >PP_0660 FitnessBrowser__Putida:PP_0660 MSVQTTTTRNASAHTFKQDMQTRHIVMLALGGVIGTGLFLTSGYTVNQAGPLGAVIAYIL GAIMVYLVMMCLGELAVHMPEVGSFSSYATRYLGPGTGYMVAWMYWLTWTVAIGSEFTAA GILMVRWFPDTPVWMWSALFGAAVFISNIISVRSFAETEFWLSLVKVLAVIAFLVVGGGA ILGGFEIQQAHSAGLGNFTREGLFPTGFWSIAMTLLAVAFAFSGTELIGIAAGETKDPEK NVPKAIRTTVLRLALFFIGTIFVLATLLPREQAGVIESPFVMVFAMIGIPYAADIMNFVI ITALLSAANSGLYAASRMLWTLSDQGNMPRRYATLSRRGTPFNAIVLSMAGGMASLLSSV FAPDTIYLALVSISGLAVVVVWISIAASQIAFRRHYIASGGKLEDLKFRVRGYPFVPLGA IFCCVLACVGIAFDPAQRVALYFGLPFIAWCYLAYWLTCKYRSRRTAPLEIVAPGSEAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server